Associated with risk of liver damage and hepatic failure.
It is recommended to monitor the serum aminotransferase before therapy and every two weeks on treatment.
Associated with risk of liver damage and hepatic failure.
It is recommended to monitor the serum aminotransferase before therapy and every two weeks on treatment.